


Idorsia Pharmaceuticals
Pharmaceutical Manufacturing • Allschwil, Basel-Country, Switzerland • 501-1000 Employees
Company overview
| Headquarters | Hegenheimermattweg 91, Allschwil, 4123, CH |
| Phone number | +41588440106 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Employees | 501-1000 |
| Socials |
Key Contacts at Idorsia Pharmaceuticals
Lisa Ma
Senior Clinical Director For Aap
Charlotte Mavet
Marketing Director Spain
Howard Wiseman
Vp Marketing Canada, Global Sr. Marketing Director
Alexis Asimakopoulos
Director, Strategic Planning, Analytics, Digital Transformation & Rewards
Daniel Szerman
Finance Director Dach
Loretta Mameli
Senior Marketing, Market Access And Public Affairs Director
Jose Maria Maurer
Sr. Finance Director
Daniel Cassidy
Senior Director, Customer Insights & Analytics
Lukasz Zemelka
Sap System Owner And Technical Consultants Lead
Chris Manginelli
Director, Professional Education And Partnership Communications
Idorsia Pharmaceuticals Email Formats
Idorsia Pharmaceuticals uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@idorsia.com), used 57.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@idorsia.com | 57.7% |
{first name}.{last name} | john.doe@idorsia.com | 40.2% |
About Idorsia Pharmaceuticals
The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients. We have more ideas, we see more opportunities, and we want to transform the horizon of therapeutic options. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options. See our LinkedIn community guidelines: https://bit.ly/4nAfOZp Idorsia privacy policy: https://www.idorsia.com/legal/privacy-policy
Idorsia Pharmaceuticals revenue & valuation
| Annual revenue | $252,600,000 |
| Revenue per employee | $348,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $808,200,000 |
| Total funding | $1,031,200,000 |
Employees by Management Level
Total employees: 501-1000
Seniority
Employees
Employees by Department
Idorsia Pharmaceuticals has 276 employees across 16 departments.
Departments
Number of employees
Funding Data
Explore Idorsia Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.
Idorsia Pharmaceuticals Tech Stack
Discover the technologies and tools that power Idorsia Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
CDN
Security
Video players
Web servers
CMS
JavaScript libraries
Webmail
Security
Analytics
UI frameworks
CRM
Frequently asked questions
4.8
40,000 users



